ENTHERA
Enthera is a new Italian biotech start-up whose mission is to find new therapeutic approaches to treat diabetes and related gastrointestinal complication (enteropathy), as well as other intestinal disorders sharing the same biological pathway. Its name comes from the crasis of the terms entero (referring to the intestine) and therapy. Enthera was founded by BiovelocITA in October 2016 in collaboration with the scientists: Prof. Paolo Fiorina and Dr. Francesca D’Addio.
ENTHERA
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2016-10-01
Address:
Milano, Lombardia, Italy
Country:
Italy
Website Url:
http://www.entherapharmaceuticals.com
Total Employee:
1+
Status:
Active
Contact:
+39 02 3456778
Total Funding:
39 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Board_member
Board_member
2020-07-01
Board_member
Current Employees Featured
Francesca D'Addio Co-founder and inventor @ Enthera
Co-founder and inventor
Gabriella Camboni CEO and co-Founder @ Enthera
CEO and co-Founder
Paolo Fiorina Co-Founder and Inventor @ Enthera
Co-Founder and Inventor
Founder
Investors List
Roche Venture Fund
Roche Venture Fund investment in Series A - Enthera
Indaco Venture Partners
Indaco Venture Partners investment in Series A - Enthera
Arepo Fiduciaria
Arepo Fiduciaria investment in Series A - Enthera
Sofinnova Partners
Sofinnova Partners investment in Series A - Enthera
Banor SIM
Banor SIM investment in Series A - Enthera
JDRF T1D Fund
JDRF T1D Fund investment in Series A - Enthera
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Enthera
Sofinnova Partners
Sofinnova Partners investment in Seed Round - Enthera
Official Site Inspections
http://www.entherapharmaceuticals.com Semrush global rank: 7.72 M Semrush visits lastest month: 440
- Host name: carnage.evtel.com
- IP address: 18.156.43.197
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Enthera"
Enthera – First-in-class therapeutics for auto-immune …
About Us We develop first-in-class biologics for several underserved autoimmune conditions. Our therapeutic approach aims to preserve and re-establish organ cell function, transforming the treatment paradigm for intractable autoimmune …See details»
Management Team – Enthera
This website uses only technical cookies and does not perform any profiling or collection of personal data through cookies. Simply browsing the website does not require the user’s …See details»
Enthera Pharmaceuticals - LinkedIn
We are excited to participate in the 19th Congress of the European Crohn´s and Colitis Organization - ECCO'24 (ecco-ibd.eu) conference on February 21st-24th in Stockholm. Enthera Pharmaceuticals ...See details»
Enthera - Crunchbase Company Profile & Funding
Enthera is a biotech manufacturing company that develops biotherapeutics treatments for underserved auto-immune disorders.See details»
Enthera Pharmaceuticals: Contact Details and Business Profile
Enthera Pharmaceuticals is a Pharmaceutical Manufacturing company located in IT with 21 employees. Find top employees, contact details and business statistics at RocketReach.See details»
Enthera Pharmaceuticals - VentureRadar
DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and …See details»
Enthera 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Enthera. Use the PitchBook Platform to explore the full profile.See details»
Overview, News & Similar companies - ZoomInfo.com
Mar 7, 2023 View Enthera Pharmaceuticals (www.entherapharmaceuticals.com) location in Lombardy, Italy , revenue, industry and description. Find related and similar companies as well …See details»
About Us – Enthera
Novel therapeutic concept Our pioneering approach is to target IGFBP3/TMEM219, a novel stem cell apoptosis pathway involved in the development and progression of several autoimmune …See details»
Enthera - Company Profile - Tracxn
Jan 16, 2025 Enthera - Developer of biotherapeutics for treating auto-immune disorders and type-1 diabetes. Raised a total funding of $45.9M over 3 rounds from 5 investors. Founded by …See details»
Enthera Pharmaceuticals - Craft
Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication. Its …See details»
Enthera - INDACO
Enthera is an Italian biotech start-up building a pipeline of first-in-class biologics for several underserved autoimmune conditions, with a focus on Type 1 Diabetes (T1D) and Inflammatory …See details»
Enthera Pharmaceuticals — Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a …See details»
Enthera Pharmaceuticals Appoints Aled Williams as Chief Executive ...
Milan, Italy, 4 May 2022 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel …See details»
Enthera Pharmaceuticals appoints Lisa M. Olson as CEO and …
Jan 23, 2024 Industry veteran Dr. Olson moves from Enthera’s Board to take the helm as CEO Ent001 Phase 1a trial in healthy volunteers completed with positive topline safety results …See details»
Enthera Pharmaceuticals extends Series A financing, raising a total …
Jan 28, 2021 Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings …See details»
Media Centre – Enthera
Feb 20, 2024 Enthera Pharmaceuticals (“Enthera”), a clinical-stage biotech company developing first-in-class antibody therapeutics targeting the Insulin Growth Factor Binding Protein (IGFBP) …See details»
Enthera Pharmaceuticals - VentureRadar
Dansk Biotek DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in …See details»
Eterna Therapeutics Changes Name to Ernexa Therapeutics to
1 day ago --Eterna Therapeutics, a leader in cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the company’ s new name: Ernexa Therapeutics …See details»
Pipeline – Enthera
Novel therapeutic concept With our proprietary discovery platform, we are developing a pipeline of first-in-class, safe and effective therapeutics for autoimmune diseases with high unmet …See details»